N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]ethenesulfonamide
Modify Date: 2025-09-24 14:26:50
![N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]ethenesulfonamide Structure](https://image.chemsrc.com/caspic/473/1246203-35-9.png)
N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]ethenesulfonamide structure
|
Common Name | N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]ethenesulfonamide | ||
|---|---|---|---|---|
| CAS Number | 1246203-35-9 | Molecular Weight | 543.546 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 755.2±70.0 °C at 760 mmHg | |
| Molecular Formula | C24H23F2N7O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 410.5±35.7 °C | |
| Name | N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]ethenesulfonamide |
|---|---|
| Synonym | More Synonyms |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 755.2±70.0 °C at 760 mmHg |
| Molecular Formula | C24H23F2N7O4S |
| Molecular Weight | 543.546 |
| Flash Point | 410.5±35.7 °C |
| Exact Mass | 543.150024 |
| PSA | 132.74000 |
| LogP | 2.50 |
| Vapour Pressure | 0.0±2.5 mmHg at 25°C |
| Index of Refraction | 1.681 |
| InChIKey | UIEJHTFJSXQWCZ-UHFFFAOYSA-N |
| SMILES | C=CS(=O)(=O)Nc1ccc(-c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4c(OC)cccc43)n2)cc1 |
|
~%
N-[4-[4-[2-(dif... CAS#:1246203-35-9 |
| Literature: PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; Location in patent: Page/Page column 46; 82-84 ; WO 2012/044641 A1 |
|
~%
N-[4-[4-[2-(dif... CAS#:1246203-35-9 |
| Literature: PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; WO 2012/044641 A1 |
|
~%
N-[4-[4-[2-(dif... CAS#:1246203-35-9 |
| Literature: PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; WO 2012/044641 A1 |
![4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline structure](https://image.chemsrc.com/caspic/011/1246203-34-8.png)
![tert-butyl N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]carbamate structure](https://image.chemsrc.com/caspic/049/1246203-33-7.png)
![N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]-2-(dimethylamino)ethanesulfonamide structure](https://image.chemsrc.com/caspic/087/1246203-32-6.png)
CAS#:1246203-32-6| N-(4-{4-[2-(Difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl}phenyl)ethenesulfonamide |
| Ethenesulfonamide, N-[4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]- |
| N-(4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)ethenesulfonamide |
| N-{4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}ethylenesulfonamide |
| N-(4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl)-6-(4-morpholinyl)-1,3,5-triazin-2-yl)phenyl)vinylsulfonamide |